IBDEI1J2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25534,1,3,0)
 ;;=3^Sepsis-Staphylococcus
 ;;^UTILITY(U,$J,358.3,25534,1,4,0)
 ;;=4^A41.2
 ;;^UTILITY(U,$J,358.3,25534,2)
 ;;=^5000204
 ;;^UTILITY(U,$J,358.3,25535,0)
 ;;=A41.52^^124^1247^115
 ;;^UTILITY(U,$J,358.3,25535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25535,1,3,0)
 ;;=3^Septicemia-Pseudomonas
 ;;^UTILITY(U,$J,358.3,25535,1,4,0)
 ;;=4^A41.52
 ;;^UTILITY(U,$J,358.3,25535,2)
 ;;=^5000209
 ;;^UTILITY(U,$J,358.3,25536,0)
 ;;=A41.51^^124^1247^113
 ;;^UTILITY(U,$J,358.3,25536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25536,1,3,0)
 ;;=3^Septicemia-E. coli
 ;;^UTILITY(U,$J,358.3,25536,1,4,0)
 ;;=4^A41.51
 ;;^UTILITY(U,$J,358.3,25536,2)
 ;;=^5000208
 ;;^UTILITY(U,$J,358.3,25537,0)
 ;;=A41.59^^124^1247^114
 ;;^UTILITY(U,$J,358.3,25537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25537,1,3,0)
 ;;=3^Septicemia-Gram Negative Organisms NEC
 ;;^UTILITY(U,$J,358.3,25537,1,4,0)
 ;;=4^A41.59
 ;;^UTILITY(U,$J,358.3,25537,2)
 ;;=^5000211
 ;;^UTILITY(U,$J,358.3,25538,0)
 ;;=A53.9^^124^1247^137
 ;;^UTILITY(U,$J,358.3,25538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25538,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,25538,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,25538,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,25539,0)
 ;;=B37.9^^124^1247^22
 ;;^UTILITY(U,$J,358.3,25539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25539,1,3,0)
 ;;=3^Candidiasis,Unspec
 ;;^UTILITY(U,$J,358.3,25539,1,4,0)
 ;;=4^B37.9
 ;;^UTILITY(U,$J,358.3,25539,2)
 ;;=^5000624
 ;;^UTILITY(U,$J,358.3,25540,0)
 ;;=B46.9^^124^1247^150
 ;;^UTILITY(U,$J,358.3,25540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25540,1,3,0)
 ;;=3^Zygomycosis, unspecified
 ;;^UTILITY(U,$J,358.3,25540,1,4,0)
 ;;=4^B46.9
 ;;^UTILITY(U,$J,358.3,25540,2)
 ;;=^5000683
 ;;^UTILITY(U,$J,358.3,25541,0)
 ;;=B59.^^124^1247^94
 ;;^UTILITY(U,$J,358.3,25541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25541,1,3,0)
 ;;=3^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,25541,1,4,0)
 ;;=4^B59.
 ;;^UTILITY(U,$J,358.3,25541,2)
 ;;=^5000734
 ;;^UTILITY(U,$J,358.3,25542,0)
 ;;=B42.9^^124^1247^119
 ;;^UTILITY(U,$J,358.3,25542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25542,1,3,0)
 ;;=3^Sporotrichosis, unspecified
 ;;^UTILITY(U,$J,358.3,25542,1,4,0)
 ;;=4^B42.9
 ;;^UTILITY(U,$J,358.3,25542,2)
 ;;=^5000657
 ;;^UTILITY(U,$J,358.3,25543,0)
 ;;=B36.9^^124^1247^130
 ;;^UTILITY(U,$J,358.3,25543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25543,1,3,0)
 ;;=3^Superficial mycosis, unspecified
 ;;^UTILITY(U,$J,358.3,25543,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,25543,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,25544,0)
 ;;=B78.9^^124^1247^127
 ;;^UTILITY(U,$J,358.3,25544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25544,1,3,0)
 ;;=3^Strongyloidiasis, unspecified
 ;;^UTILITY(U,$J,358.3,25544,1,4,0)
 ;;=4^B78.9
 ;;^UTILITY(U,$J,358.3,25544,2)
 ;;=^5000791
 ;;^UTILITY(U,$J,358.3,25545,0)
 ;;=B58.9^^124^1247^139
 ;;^UTILITY(U,$J,358.3,25545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25545,1,3,0)
 ;;=3^Toxoplasmosis, unspecified
 ;;^UTILITY(U,$J,358.3,25545,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,25545,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,25546,0)
 ;;=M79.1^^124^1247^74
 ;;^UTILITY(U,$J,358.3,25546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25546,1,3,0)
 ;;=3^Myalgia
 ;;^UTILITY(U,$J,358.3,25546,1,4,0)
 ;;=4^M79.1
 ;;^UTILITY(U,$J,358.3,25546,2)
 ;;=^5013321
 ;;^UTILITY(U,$J,358.3,25547,0)
 ;;=R76.11^^124^1247^2
 ;;^UTILITY(U,$J,358.3,25547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25547,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
